Energy Boost For Fatigued Cancer PatientsJune 11, 2002
Fatigue is one of the most common side effects of treatment for cancer, robbing patients of the energy to perform everyday tasks and severely impairing their quality of life.
But Italian scientists have found that giving people a substance called levocarnitine - which is taken in a pineapple flavoured drink - seems to help them recover from the effects of treatment. In their study, 90 per cent of those who received the supplement recovered from their fatigue within a week.
Scientists believe many cases of fatigue - which affects 80 per cent of patients receiving chemotherapy - occur when treatment disrupts a patient's metabolism. This depletes levels of a molecule called carnitine, which is vital for providing energy to our muscles.
Lead researcher Dr Francesco Graziano, of Urbino Hospital in Italy, comments: "After chemotherapy, many patients have low levels of carnitine in their blood and we think that's one of the reasons they feel so exhausted. It seemed logical that boosting carnitine levels with a dietary supplement might restore that lost energy. Our study was the first to take this new approach to treating fatigue and the results, although preliminary, were very encouraging."
Dr Graziano and his colleagues studied 50 patients who had reported feeling fatigue during the course of their chemotherapy. They used detailed questionnaires to assess each patient's degree of fatigue and took blood samples to measure carnitine levels.
Researchers then gave patients an energy drink containing levocarnitine, which is converted to carnitine in the body. After a week of treatment, their progress was assessed.
On average, blood carnitine levels increased by 50 per cent over the course of the week. And the questionnaires revealed that 45 of the 50 patients (90 per cent) no longer felt fatigued.
Dr Graziano adds: "The quality of life of our patients improved markedly over the course of the week, and it seems likely that the improvements were a result of the supplements they were taking.
"We now need larger-scale trials, to test the extent to which the supplement can restore patients' energy levels. It could become an important way of maintaining quality of life for patients undergoing intensive treatment for cancer."
Prof Gordon McVie of Cancer Research UK, owners of the British Journal of Cancer, says: "Treating patients more effectively doesn't just mean keeping them alive for longer; it also means preserving their quality of life.
"We are getting better at reducing the side effects associated with modern drugs, but chemotherapy still robs many patients of the energy they need to live their life to the full. A simple dietary supplement to restore a patient's zip would be a valuable step forward and these initial results are certainly encouraging."
Cancer Research UK
Related Chemotherapy Current Events and Chemotherapy News Articles
Imprint of chemotherapy linked to inflammation in breast cancer survivors
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Common cancers evade detection by silencing parts of immune system cells
Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body's immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment.
Brisbane's drinking water linked to infections
Brisbane's water supply has been found to contain disease carrying bugs which can be directly linked to infections in some patients, according to a new study by QUT.
Let there be tissue-penetrating light: Scientists develop new nanoscale method to fight cancer
Researchers from UCLA's Jonsson Comprehensive Cancer Center have developed an innovative cancer-fighting technique in which custom-designed nanoparticles carry chemotherapy drugs directly to tumor cells and release their cargo when triggered by a two-photon laser in the infrared red wavelength.
Fox Chase Researchers Discover New Mechanism of Gene Regulation
In the cells of humans and other organisms, only a subset of genes are active at any given time, depending largely on the stage of life and the particular duties of the cell.
Scientists explore promising new option for first line of attack in lymphoma
Follicular lymphoma is a type of non-Hodgkin's lymphoma- a blood cancer - that usually develops slowly. The majority of patients are diagnosed when their disease is at an advanced stage.
Second-most common breast cancer subtype may benefit from personalized treatment approach
The second-most common type of breast cancer is a very different disease than the most common and appears to be a good candidate for a personalized approach to treatment, according to a multidisciplinary team led by University of Pittsburgh Cancer Institute (UPCI) scientists.
Large Study Shows Preventive Ovarian Surgery in BRCA1 Mutation Carriers Should Be Performed Early for Greatest Benefit
The findings of a large international prospective study published in the Journal of Clinical Oncology suggest for the first time that women with BRCA1 mutations should have preventive ovarian surgery (prophylactic oophorectomy) by age 35, as waiting until a later age appears to increase the risk of ovarian cancer before or at the time of the preventive surgery.
Promising cervical cancer study
Research on cervical cancer performed by a physician at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center has been published in the New England Journal of Medicine.
Computerized checklist reduces type of hospital infection, Stanford/Packard study finds
A computerized safety checklist that automatically pulls information from patients' electronic medical records was associated with a threefold drop in rates of one serious type of hospital-acquired infection, according to a study by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford.
More Chemotherapy Current Events and Chemotherapy News Articles